Tag: U.S. Food and Drug Administration

Industry News
Gilead Resubmitted New Drug Application for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitorto U.S. Food and Drug Administration

Gilead Resubmitted New Drug Application for Lenacapavir,...

On June 27, 2022,- Gilead Sciences, Inc. announced the resubmission of the New Drug...